期刊文献+

195例声门型喉癌放疗近期生存分析 被引量:6

Short-term survival analysis of 195 glottis cancer patients treated by radiotherapy
下载PDF
导出
摘要 目的 对解放军总医院经放疗的195例声门型喉癌(glottic cancinoma,GC)患者进行近期生存分析.方法 2007年7月-2013年4月解放军总医院收治195例经放疗的声门型喉癌患者,其中30例接受根治性放疗,165例行术后辅助放疗.放疗采取三维适形放疗(three dimensional conformal radiotherapy,3D-CRT)和调强放疗(intensity modified radiotherapy,IMRT)技术,根治性放疗处方剂量:64.5~70 Gy/33 ~ 35 F,高危计划靶区50 ~ 60 Gy/30 ~ 33 F,低危计划靶区44 ~ 54 Gy/22~ 33 F.结果 中位随访时间36.7个月,全组病例3年无局部复发生存率(local relapse-free survival,LRFS)、无区域复发生存率(regionalrelapse-free survival,RRFS)、无远处转移生存率(metastasis-free survival,MFS)及总生存率(overall survival,OS)分别为91.3%、96.8%、94.2%、90.6%;5年累积生存率分别为88.2%、96.8%、91.7%和83.5%.T分期及临床分期影响患者3年LRFS、MFS及OS,而有无淋巴结转移则影响患者3年RRFS及MFS.多次手术与仅行1次手术患者相比,3年MFS明显降低(x^2=8.810,P=O.003);Cox回归证实手术次数和是否有淋巴结转移是影响患者3年MFS的独立因素;而影响患者3年OS的独立预后因素包括年龄及T分期.结论 声门型喉癌整体预后较好,放疗在其综合治疗中意义重大,影响GC 3年OS的主要因素为年龄和T分期,手术次数及淋巴结转移则影响3年MFS,手术是放疗失败后GC的有效挽救方式. Objective To evaluate the preliminary clinical results of 195 glottis cancer (GC) patients treated by three dimensional conformal radiotherapy (3D-CRT) or intensity modified radiotherapy (IMRT). Methods From July 2007 to April 2013 in Chinese PLA general hospital, 195 newly diagnosed GC patients were treated with radiotherapy, including 30 cases for radical treatment and 165 cases for adjuvant irradiation. The prescription dose was 64.5-70 Gy/33-35 F to the radical target, 50-60 Gy/30-33 F to the high risk target, and 44-54 Gy/22-33 F to the low risk target. Results The median follow up time was 36.7 months (range, 6 to 77 months). The local relapse-free survival (LRFS), regional relapse-free survival (RRFS), distant metastasis-free survival (MFS) and overall survival (OS) were 91.3%, 96.8%, 94.2% and 90.6% for 3 years, 88.2%, 96.8%, 91.7% and 83.5% for 5 years, respectively. The T stage and clinical stage could affect the 3-year LRFS, MFS and OS of patients. There was significant difference in 3-year RRFS and MFS between the patients at stage cN+ and cN-. Three year MFS in patients for one time resection were lower than those for more than once (X^2=8.810, P=0.003). Multivariate analysis showed that times of resection and cN + influenced the 3-year MFS (P=0.02) and age and T stage influenced the 3-year OS (P 〈 0.05). Conclusion The GC patients have good prognosis on the whole. Radiotherapy plays a very important role in comprehensive treatment for GC patients. Age and T stage can influence the 3-year OS and times of resection and cN + can influence the 3-year MFS. Salvage treatment is effective for the failure cases.
出处 《解放军医学院学报》 CAS 2014年第12期1209-1213,共5页 Academic Journal of Chinese PLA Medical School
关键词 声门型喉癌 放疗 生存率 glottic cancinoma radiotherapy survival rate
  • 相关文献

参考文献8

二级参考文献102

共引文献144

同被引文献76

  • 1Novin K, Ameri A, Faraji S, et al. Head and Neck Squa- mous Cell Carcinoma in Iran: Clinico-Pathological and Treatment-Related Factors Influencing Survival [ J 1. Iran J Cancer Prey, 2015,8 ( 5 ) : e3842. 被引量:1
  • 2Lu Y,Gao W,Zhang C,et al. Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4 [ J ]. J Cancer, 2015,6 (12) : 1260 - 1275. 被引量:1
  • 3Kopta R, Mochocki M, Morawski P, et al. Expression of Thl7 cell population regulatory cytokines in laryngeal car-cinoma-Preliminary study [ J 1- Contemp Oncol ( Pozn ), 2015,19(3) :195 -200. 被引量:1
  • 4Liu F,Du J,Xian J,et al. Improved therapeutic effective- ness by combining recombinant p14 (ARF) with antisense complementary DNA of EGFR in laryngeal squamous cell carcinoma~J~. Am J Otolaryngol,2015,36(6) :763 -771. 被引量:1
  • 5Anders QS,Stur E, Agostini LP, et al. MTHFR C677T and A1298C polymorphisms as predictors of radiotherapy re- sponse in head and neck squamous cell carcinoma [ J]. Genet Mol Res,2015,14(4) : 13105 - 13109. 被引量:1
  • 6Zhong G, Xiong X. miR-205 promotes proliferation and in- vasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression[ J]. Biol Res,2015,48:60. 被引量:1
  • 7Yu W,Zhang G,Lu B,et al. miR-340 impedes the progres- sion of laryngeal squamous cell carcinoma by targeting EZH2 [ J ]. Gene, 2016,577 ( 2 ) : 193 - 201. 被引量:1
  • 8耿美香,王桂芳,黄观辉,翟军印,王庭良.低温等离子微创治疗早期声门型喉癌的近期疗效观察[J].临床医学工程,2010,17(12):76-77. 被引量:7
  • 9黄卫华,曾新力,应海岳,张卓铭,黄力真,汪际云.低温等离子刀射频消融治疗早期声门型喉癌疗效观察[J].现代实用医学,2012,24(3):332-333. 被引量:26
  • 10程良军,刘冰,田爱民,明昊.低温等离子射频消融术治疗早期声带癌的初步探讨[J].临床耳鼻咽喉头颈外科杂志,2013,27(3):153-154. 被引量:12

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部